Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma
Public ClinicalTrials.gov record NCT05564091. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A prospective, multicenter, randomized, single-masked, post-market clinical trial comparing cataract surgery in conjunction with ab-interno canaloplasty utilizing the iTrack Advance canaloplasty device (Nova Eye, Inc.) to cataract surgery only in patients with mild to moderate, primary open angle glaucoma. Subjects will be followed for 24 months.
Study identification
- NCT ID
- NCT05564091
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 78 participants
Conditions and interventions
Conditions
Interventions
- Cataract surgery Procedure
- Cataract surgery combined with ab-interno canaloplasty utililzing the iTrack Advance canaloplasty device Device
Procedure · Device
Eligibility (public fields only)
- Age range
- 55 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 7, 2022
- Primary completion
- May 31, 2027
- Completion
- Jun 30, 2027
- Last update posted
- Apr 17, 2025
2022 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Berkeley Eye Center | Sugar Land | Texas | 77478 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
Recently updated Primary Open Angle Glaucoma trials
Other public records listing Primary Open Angle Glaucoma. Sorted by last update posted; newest first. Not a recommendation.
- NCT05695027: Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study Active, not recruiting
- NCT04553523: Hydrus® Microstent New Enrollment Post-Approval Study Recruiting
- NCT07619482: Topical Insulin for Glaucoma (TING2) Not yet recruiting
- NCT06822738: A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma Recruiting
- NCT07390890: DSLT for Reducing Medication in Glaucoma Recruiting
- NCT00221897: Diagnostic Innovations in Glaucoma Study Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05564091, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 17, 2025 · Synced Aug 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05564091 live on ClinicalTrials.gov.